{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:41:50Z","timestamp":1759333310001},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1998,12,1]],"date-time":"1998-12-01T00:00:00Z","timestamp":912470400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[1998,12]]},"DOI":"10.1007\/s10787-998-0013-5","type":"journal-article","created":{"date-parts":[[2007,7,27]],"date-time":"2007-07-27T02:25:52Z","timestamp":1185503152000},"page":"289-296","source":"Crossref","is-referenced-by-count":6,"title":["Pro-inflammatory properties of the kallikrein-kinin system: Potential for new drug therapy"],"prefix":"10.1007","volume":"6","author":[{"given":"J. N.","family":"Sharma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. P. M.","family":"Yusof","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"13_CR1","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1600-0773.1988.tb00960.x","volume":"63","author":"JN. Sharma","year":"1988","unstructured":"Sharma JN. The kinin system and prostaglandins in the intestine. Pharmacol Toxicol. 1988;63:310\u201316.","journal-title":"Pharmacol Toxicol"},{"key":"13_CR2","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0940-2993(11)80053-9","volume":"46","author":"JN Sharma","year":"1996","unstructured":"Sharma JN, Buchanan WW. Pathogenic responses of bradykinin system in chronic inflammatory rheumatoid disease. Exp Toxicol Pathol. 1996;46:421\u201333.","journal-title":"Exp Toxicol Pathol"},{"key":"13_CR3","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0232-1513(11)80241-0","volume":"38","author":"JN Sharma","year":"1990","unstructured":"Sharma JN, Mohsin SSJ. The role of chemical mediators in the pathogenesis of inflammation with emphasis on the kinin system. Exp Pathol. 1990;38:73\u201396.","journal-title":"Exp Pathol"},{"key":"13_CR4","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0306-3623(83)90001-0","volume":"14","author":"F Marceau","year":"1983","unstructured":"Marceau F, Lussier A, Regoli D, Giroud JP. Pharmacology of kinins: their relevance to tissue injury and inflammation. Gen Pharmacol. 1983;14:209\u201329.","journal-title":"Gen Pharmacol"},{"key":"13_CR5","first-page":"l","volume":"32","author":"D Regoli","year":"1980","unstructured":"Regoli D, Barabe J. Pharmacology of bradykinin and related kinins. Pharmacol Rev. 1980;32:l-42.","journal-title":"Pharmacol Rev"},{"key":"13_CR6","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0196-9781(85)90033-6","volume":"6","author":"RJ Vavrek","year":"1985","unstructured":"Vavrek RJ, Stewart JM. Competitive antagonists of bradykinin. Peptides. 1985;6:161\u20134.","journal-title":"Peptides"},{"key":"13_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ddr.430160102","volume":"16","author":"JE Taylor","year":"1989","unstructured":"Taylor JE, DeFeudis FV, Moreau JP. Bradykinin antagonists: therapeutic perspectives. Drug Devel Res. 1989;16:1\u201311.","journal-title":"Drug Devel Res"},{"key":"13_CR8","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/978-1-4615-9543-4_28","volume":"247A","author":"JN. Sharma","year":"1989","unstructured":"Sharma JN. Contribution of kinin system to the antihypertensive action of angiotensin converting enzyme inhibitors. Adv Exp Med Biol. 1989;247A:197\u2013205.","journal-title":"Adv Exp Med Biol"},{"key":"13_CR9","first-page":"279","volume":"262","author":"JN Sharma","year":"1983","unstructured":"Sharma JN, Zeitlin IJ, Deodhar SD, Buchanan WW. Detection of kallikrein-like activity in inflamed synovial tissue. Arch Int Pharmacodyn Ther. 1983;262:279\u201386.","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"13_CR10","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/978-3-642-67301-6_12","volume":"25","author":"EG. Erods","year":"1979","unstructured":"Erods EG. Kininases. Hand Exp Pharmacol. 1979;25:427\u201348.","journal-title":"Hand Exp Pharmacol"},{"key":"13_CR11","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0306-3623(88)90058-4","volume":"19","author":"JN. Sharma","year":"1988","unstructured":"Sharma JN. Interrelationship between the kallikrein kinin system and hypertension. Gen Pharmacol. 1988;19:177\u201387.","journal-title":"Gen Pharmacol"},{"key":"13_CR12","first-page":"147","volume-title":"Renal Function, Hypertension and Kallikrein-Kinin System","author":"JN. Sharma","year":"1988","unstructured":"Sharma JN. The kallikrein-kinin system in hypertension. In: Limura O, Margolius HS, eds. Renal Function, Hypertension and Kallikrein-Kinin System. Tokyo: University of Tokyo Press; 1988:147\u201354."},{"key":"13_CR13","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/978-1-4757-0154-8_52","volume":"198B","author":"HA Al-Haboubi","year":"1986","unstructured":"Al-Haboubi HA, Bennett D, Sharma JN, Thomas GR, Zeitlin IJ. A synovial amidase acting on tissue kallikrein-selective substrate in clinical and experimental arthritis. Adv Exp Med Biol. 1986;198B:405\u201311.","journal-title":"Adv Exp Med Biol"},{"key":"13_CR14","first-page":"336","volume":"11","author":"W M\u00fcller-Esteri","year":"1986","unstructured":"M\u00fcller-Esteri W, Iwanaga S, Nakanishi S. Kininogens revisited. TIBS. 1986;11:336\u20139.","journal-title":"TIBS"},{"key":"13_CR15","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/0006-291X(83)91519-X","volume":"112","author":"H Okamoto","year":"1983","unstructured":"Okamoto H, Greenbaum LM. Isolation and structure of T-kinin. Biochem Biophys Res Commun. 1983;112:701\u20138.","journal-title":"Biochem Biophys Res Commun"},{"key":"13_CR16","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0014-5793(88)80545-3","volume":"239","author":"A-L Lattion","year":"1988","unstructured":"Lattion A-L, Baussant T, Alhenc-Gelas F, Seidah NG, Corvol P, Soubrier F. The high-molecular-mass kininogen deficient rat expresses all kininogen mRNA species, but does not export the high-molecular-mass kininogen synthesized. FEBS Lett. 1988;239:59\u201363.","journal-title":"FEBS Lett"},{"key":"13_CR17","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/BF00501189","volume":"276","author":"EP Zach","year":"1973","unstructured":"Zach EP, Werle E. Uber den kininogengehalt von serum und Plasma nach Gewebschadigung bei Ratten. Arch Pharmacol. 1973;276:167\u201380.","journal-title":"Arch Pharmacol"},{"key":"13_CR18","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.2042-7158.1976.tb04021.x","volume":"28","author":"DR Borges","year":"1976","unstructured":"Borges DR, Gordon AH. Kininogen and kininogenase synthesis by the liver of normal and injured rats. J Pharm Pharmacol.1976;28:44\u20138.","journal-title":"J Pharm Pharmacol"},{"key":"13_CR19","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/path.1710990308","volume":"99","author":"CG Arman Van","year":"1969","unstructured":"VanArman CG, Nuss GW. Plasma bradykininogen levels in adjuvant arthritis and carrageenan inflammation. J Pathol. 1969;99:245\u201350.","journal-title":"J Pathol"},{"issue":"Suppl.l","key":"13_CR20","first-page":"368","volume":"9","author":"ML Reis","year":"1982","unstructured":"Reis ML, Lerne J, Suda LS. Plasma \u2018kininogen\u2019 levels in rat with adjuvant arthritis. Agents Actions. 1982;9(Suppl.l):368\u201378.","journal-title":"Agents Actions"},{"key":"13_CR21","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1016\/0006-2952(84)90590-2","volume":"33","author":"LM. Greenbaum","year":"1984","unstructured":"Greenbaum LM. T-kinin and T-kininogen. Children of new technology. Biochem Pharmacol. 1984;33:2943\u20134.","journal-title":"Biochem Pharmacol"},{"key":"13_CR22","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1007\/BF01966523","volume":"21","author":"S Oh-ishi","year":"1987","unstructured":"Oh-ishi S, Hayashi I, Utsunomiya I et al. Roles of kallikrein-kinin system in acute inflammation: studies on high- and low-molecular weight kininogen deficient rats (B\/N \u2014 Katholiek strain). Agents Actions. 1987;21:384\u20136.","journal-title":"Agents Actions"},{"key":"13_CR23","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/BF00919434","volume":"12","author":"K Sugio","year":"1988","unstructured":"Sugio K, Greenbaum LM. Increase in vascular permeability of rat and guinea pig skin by T-kinin. Inflammation. 1988;12:407\u201316.","journal-title":"Inflammation"},{"key":"13_CR24","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0014-5793(88)81134-7","volume":"229","author":"N Itoh","year":"1988","unstructured":"Itoh N, Yayama K, Okamoto H. Stimulation of hepatic T-kininogen production by interferon. FEBS Lett. 1988;229:247\u201350.","journal-title":"FEBS Lett"},{"key":"13_CR25","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/978-1-4684-3198-8_63","volume-title":"Bradykinin and Related Kinins","author":"CG VanArman","year":"1970","unstructured":"VanArman CG, Carlson RP. The two distinct phases of inflammatory responses in the dog\u2019s knee joint. In: Sicuteri F, Rochae Silva M, Back N, eds. Bradykinin and Related Kinins. New York: Plenum Press; 1970:525\u201333."},{"key":"13_CR26","doi-asserted-by":"crossref","first-page":"461P","DOI":"10.1111\/j.1476-5381.1974.tb08587.x","volume":"50","author":"SH Ferreira","year":"1974","unstructured":"Ferreira SH, Moncada S, Vane JR. Potentiation of prostaglandins of nociceptive activity of bradykinin in the dog knee joint. Br J Pharmacol. 1974;50:461P.","journal-title":"Br J Pharmacol"},{"key":"13_CR27","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/art.1780100103","volume":"10","author":"KL Melmon","year":"1967","unstructured":"Melmon KL, Webster ME, Goldfinger SE, Seegmiller JE. Presence of a kinin in inflammatory synovial effusion from arthritides of varying etiology. Arthritis Rheum. 1967;10:13\u201320.","journal-title":"Arthritis Rheum"},{"key":"13_CR28","first-page":"103","volume":"3","author":"V. Eisen","year":"1970","unstructured":"Eisen V. Formation and function of kinins. Rheumatology. 1970;3:103\u201368.","journal-title":"Rheumatology"},{"issue":"Suppl. 1","key":"13_CR29","first-page":"645","volume":"9","author":"M Katori","year":"1982;9","unstructured":"Katori M, Uchida Y, Oh-Ishi S, Sawai K. Parameters for indicating the involvement of plasma kallikrein-kinin-system in acute inflammation. Agents Actions. 1982;9(Suppl. 1):645\u20138.","journal-title":"Agents Actions"},{"key":"13_CR30","first-page":"195","volume":"120B","author":"K Sawai","year":"1979","unstructured":"Sawai K, Niwa S, Katori M. The significant reduction of high molecular weight kininogen in synovial fluid of patients with active rheumatoid arthritis. Adv Exp Med Biol. 1979; 120B:195\u2013202.","journal-title":"Adv Exp Med Biol"},{"key":"13_CR31","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1136\/ard.28.5.497","volume":"28","author":"MK Jasani","year":"1969","unstructured":"Jasani MK, Katori M, Lewis GP. Intracellular enzymes and kinin enzymes in synovial fluid in joint diseases. Ann Rheum Dis. 1969;28:497\u2013511.","journal-title":"Ann Rheum Dis"},{"key":"13_CR32","first-page":"351P","volume":"1","author":"PM Brooks","year":"1974","unstructured":"Brooks PM, Dick WC, Sharma JN, Zeitlin IJ. Changes in plasma kininogen levels associated with rheumatoid activity. Br J Clin Pharmacol. 1974;1:351P.","journal-title":"Br J Clin Pharmacol"},{"key":"13_CR33","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/BF01972199","volume":"6","author":"JN Sharma","year":"1976","unstructured":"Sharma JN, Zeitlin IJ, Brooks PM, Dick WC. A novel relationship between plasma kininogen and rheumatoid disease. Agents Actions. 1976;6:148\u201353.","journal-title":"Agents Actions"},{"key":"13_CR34","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1440-1681.1980.tb00082.x","volume":"7","author":"JN Sharma","year":"1980","unstructured":"Sharma JN, Zeitlin IJ, Brooks PM, Buchanan WW, Dick WC. The action of aspirin on plasma kininogen and other proteins in rheumatoid patients: relationship to disease activity. Clin Exp Pharmacol Physiol. 1980;7:347\u201353.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"13_CR35","first-page":"335","volume":"70","author":"IJ Zeitlin","year":"1976","unstructured":"Zeitlin IJ, Sharma JN, Brook PM, Dick WC. Raised plasma kininogen levels in rheumatoid arthritis: response to therapy by non-steroidal anti-inflammatory drugs. Adv Exp Med Biol. 1976;70:335\u201343.","journal-title":"Adv Exp Med Biol"},{"key":"13_CR36","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/art.1780300507","volume":"30","author":"UH Lerner","year":"1987","unstructured":"Lerner UH, Jones IL, Gustafson GT. Bradykinin, a new potential mediator of inflammation-induced bone resorption. Arthritis Rheum. 1987;30:530\u201340.","journal-title":"Arthritis Rheum"},{"key":"13_CR37","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0169-6009(89)90092-5","volume":"5","author":"UH Lerner","year":"1989","unstructured":"Lerner UH, Ransjo M, Ljunggren O. Bradykinin stimulates production of prostaglandin E2 and prostacyclin in murine osteoblasts. Bone Miner. 1989;5:139\u201354.","journal-title":"Bone Miner"},{"key":"13_CR38","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/BF01116860","volume":"10","author":"O Ljunggren","year":"1990","unstructured":"Ljunggren O, Resenquist J, Ransjo M et al. Bradykinin stimulated prostaglandin E2 formation in isolated human osteoblast-like cells. Biosci Res. 1990;10:121\u20138.","journal-title":"Biosci Res"},{"key":"13_CR39","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0162-3109(92)90037-D","volume":"23","author":"J Uhl","year":"1992","unstructured":"Uhl J, Singh S, Brophy L, Faunce D, Sawutz DG. Role of bradykinin in inflammatory arthritis: identification and functional analysis of bradykinin receptors on human synovial fibroblasts. Immuno-pharmacology. 1992;23:131\u20138.","journal-title":"Immuno-pharmacology"},{"key":"13_CR40","first-page":"384","volume":"260","author":"JM Bothon","year":"1992","unstructured":"Bothon JM, Manning DC, Goldman DW, Towns MC, Proud D. Characterization of kinin receptors on human synovial cells and upregulation of receptor number by interleukin-1. J Pharmacol Exp Ther. 1992;260:384\u201392.","journal-title":"J Pharmacol Exp Ther"},{"key":"13_CR41","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0090-6980(77)90005-3","volume":"13","author":"DS Newcombe","year":"1977","unstructured":"Newcombe DS, Fahey JV, Ishikawa Y. Hydrocortisone inhibition of the bradykinin activation of human synovial fibroblasts. Prostaglandins. 1977;13:235\u201344.","journal-title":"Prostaglandins"},{"key":"13_CR42","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1749-6632.1982.tb22123.x","volume":"389","author":"AP Kaplan","year":"1982","unstructured":"Kaplan AP, Silverbery M, Dunn JT, Ghebrehiwet B. Interaction of the clotting, kinin-forming, complement and fibrinolytic pathways in inflammation. Ann NY Acad Sci. 1982;389:25\u201338.","journal-title":"Ann NY Acad Sci"},{"key":"13_CR43","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0014-2999(82)90294-1","volume":"83","author":"JN Sharma","year":"1982","unstructured":"Sharma JN, Zeitlin IJ. Reduced plasma kininogen concentrations by prostaglandin E2 in rats. Eur J Pharmacol. 1982;83:119\u201321.","journal-title":"Eur J Pharmacol"},{"key":"13_CR44","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0024-3205(79)90380-1","volume":"25","author":"A Nasjletti","year":"1979","unstructured":"Nasjletti A, Malik KU. Relationship between the kallikrein and prostaglandin system. Life Sci. 1979;25:99\u2013110.","journal-title":"Life Sci"},{"key":"13_CR45","first-page":"165","volume-title":"Prostaglandin Synthetase Inhibitors","author":"GA Higgs","year":"1974","unstructured":"Higgs GA, Vane JR, Hart FD, Wojtulewski JA. Effect of anti-inflammatory drugs on prostaglandin in rheumatoid arthritis. In: Robinson HJ, Vane JR, eds. Prostaglandin Synthetase Inhibitors. New York: Raven Press; 1974:165\u201373."},{"key":"13_CR46","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1172\/JCI109483","volume":"64","author":"HH Newball","year":"1979","unstructured":"Newball HH, Berninger RW, Talamo RC, Lichtenstein LM. Anaphylactic release of a basophil kallikrein-like activity. J Clin Invest. 1979;64:457\u201366.","journal-title":"J Clin Invest"},{"key":"13_CR47","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/246215a0","volume":"246","author":"TJ Williams","year":"1973","unstructured":"Williams TJ, Morley J. Prostaglandins as potentiator of increased vascular permeability of inflammation. Nature. 1973;246:215.","journal-title":"Nature"},{"key":"13_CR48","doi-asserted-by":"crossref","first-page":"579","DOI":"10.4049\/jimmunol.143.2.579","volume":"143","author":"JM Bathon","year":"1989","unstructured":"Bathon JM, Proud D, Krackow K, Wigley FM. Preincubation of human synovial cells with IL-1 modulates prostaglandin E2 in response to bradykinin. J Immunol. 1989;143:579\u201386.","journal-title":"J Immunol"},{"key":"13_CR49","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S1043-6618(05)80112-4","volume":"23","author":"JN. Sharma","year":"1991","unstructured":"Sharma JN. The role of the kallikrein-kinin system in joint inflammatory disease. Pharmacol Res. 1991;23:105\u201312.","journal-title":"Pharmacol Res"},{"key":"13_CR50","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0306-3623(93)90302-E","volume":"24","author":"JN. Sharma","year":"1993","unstructured":"Sharma JN. Therapeutic prospects of bradykinin antagonists. Gen Pharmacol. 1993;24:267\u201374.","journal-title":"Gen Pharmacol"},{"issue":"Suppl. III","key":"13_CR51","first-page":"428","volume":"III","author":"KJ Wirth","year":"1992;38","unstructured":"Wirth KJ, Alperman HG, Satoh R, Inazu M. The bradykinin antagonist Hoe 140 inhibits carrageenan and thermally induced paw oedema in rats. Agents Actions. 1992;38(Suppl. III):428\u201331.","journal-title":"Agents Actions"},{"key":"13_CR52","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/0162-3109(96)00098-7","volume":"33","author":"L Gera","year":"1996","unstructured":"Gera L, Stewart JM. A new class of bradykinin antagonists dinners. Immunopharmacology. 1996;33:174\u20137.","journal-title":"Immunopharmacology"},{"key":"13_CR53","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0306-3623(95)00078-X","volume":"27","author":"JN Sharma","year":"1996","unstructured":"Sharma JN, Wirth KJ. Inhibition of rats adjuvant arthritis by a bradykinin antagonist Hoe 140 and its influence on kallikreins. Gen Pharmacol. 1996;27:133\u20136.","journal-title":"Gen Pharmacol"},{"key":"13_CR54","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10787-998-0002-8","volume":"6","author":"JN Sharma","year":"1998","unstructured":"Sharma JN, Yusof APM, Wirth KJ. The kinin antagonist Hoe 140 reduces acute paw oedema in rats caused by carrageenan, bradykinin and kaolin. Inflammopharmacology. 1998;6:9\u201317.","journal-title":"Inflammopharmacology"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-998-0013-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10787-998-0013-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-998-0013-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,13]],"date-time":"2023-05-13T15:41:33Z","timestamp":1683992493000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10787-998-0013-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,12]]},"references-count":54,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1998,12]]}},"alternative-id":["13"],"URL":"https:\/\/doi.org\/10.1007\/s10787-998-0013-5","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,12]]}}}